1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Europe Ultra-Low Temperature Freezer Market to 2027 – Regional Analysis and Forecasts by Type ; End User ; and, Country

Europe Ultra-Low Temperature Freezer Market to 2027 – Regional Analysis and Forecasts by Type ; End User ; and, Country

  • August 2020
  • 130 pages
  • ID: 5953788
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Dec 10th 2020

Summary

Table of Contents

Search Inside

Europe ultra-low temperature freezer market is anticipated to reach US$ 186.03 million by 2027 from US$ 138.93 million in 2019. The market is projected to grow with a CAGR of 3.9% from 2019 to 2027.
The growth of the ultra-low temperature freezer market is primarily attributed to the rising government support for research activities and clinical trials.Growing use of refurbished equipment is likely to damage the growth of the market in the coming years.

On the other hand, development in the healthcare market is expected to have a positive impact on the growth of the Europe ultra-low temperature freezer market in the coming years.
Ultra-low temperature freezers are designed for storage of biological materials such as virus, bacteria, eukaryotic cells, blood, and semen. These freezers are used in blood banks, hospitals, epidemic prevention services, research institutes, and biomedical engineering facilities, among others.
The clinical trials industry has seen a phenomenal increase in the last 10 years.Vaccine development against COVID-19 is picking up pace as various companies have started clinical trials and forming collaborations to ensure rapid growth and sufficient production capacity.

The UK government has committed to providing £84 million funding to researchers working on the COVID-19 vaccine program. Additionally, the US government has agreed to fund US$ 483 million for Moderna Inc. to develop and test its COVID-19 vaccine, which is now in an initial clinical trial. Additionally, the European Commission has been funding projects to develop vaccines, treatments, and diagnostics via grants from Horizon 2020 and the Innovative Medicines Initiative (IMI), which announced up to US$ 50 million in public grants. The biotech industry in Europe is playing a vital part in the fight against COVID-19, in terms of developing vaccines, therapeutic drugs, diagnostics, and research. For instance, The European Commission offered US$ 89 million Euros to CureVac on March 17, 2020, to develop the vaccine. Hence, government funding for research activities and clinical trials will increase the development of new therapies, thereby propelling the adoption of ultra-low temperature freezers as the new developing advanced treatments are derived from human cells, either by retaining or changing some specific living, complex molecular attributes. These materials are susceptible to temperature change and are most often frozen at -70°C to -90°C.
Moreover, most of the sectors in Europe are affected by the spread of COVID-19.In response to this, central banks have cut down the interest rates in many countries.

However, the ultra-low temperature freezer market is expected to get affected by this pandemic for a short period of time, Germany and the UK are the most affected due to presence of major research center in the countries.Most of the companies are engaged in the development of therapeutic alternatives for COVID-19.

This has put off all the research and development activities of stem cells, personalized medicine, and other therapies.
In terms of type, the upright ULT freezers segment accounted for the largest share of the Europe ultra-low temperature freezer market in 2019 and is estimated to mark the highest CAGR in the market during the forecast period, owing to the factors such as easier to organize because of having shelves. Also, the convenience of use of upright freezers has led to its dominance during 2019 and is expected to witness similar trend over the coming years.
German Biobank Node (GBN), GBN (GBA), Global Stem Cell & Regenerative Medicine Acceleration Center (Global Stem Cell & Regenerative Medicine Acceleration Center), and Global Stem Cell & Regenerative Medicine Acceleration Center (ISSCA ) are among the significant primary and secondary sources for ultra-low temperature freezer included in the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Middle East & Africa Pipette Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type ; Category ; Channel ; Volume ; Application and Country

  • $ 3000
  • October 2020
  • 138 pages

The Middle East & Africa pipette market is expected to reach US$ 69.85 million by 2027 from US$ 58.47 million in 2019. The market is estimated to grow with a CAGR of 2.4% from 2020–2027. The growth ...

  • Middle East
  • Africa
  • Pharmaceutical
  • Biotechnology
  • Industry analysis
  • Health Expenditure
  • Final Consumption Expenditures

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on